Details for New Drug Application (NDA): 020222
✉ Email this page to a colleague
The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 020222
Tradename: | COLESTID |
Applicant: | Pfizer |
Ingredient: | colestipol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020222
Mechanism of Action | Bile-acid Binding Activity |
Medical Subject Heading (MeSH) Categories for 020222
Suppliers and Packaging for NDA: 020222
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222 | NDA | Pharmacia & Upjohn Company LLC | 0009-0450 | 0009-0450-03 | 120 TABLET in 1 BOTTLE (0009-0450-03) |
COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222 | NDA AUTHORIZED GENERIC | Greenstone LLC | 59762-0450 | 59762-0450-1 | 120 TABLET in 1 BOTTLE (59762-0450-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
Approval Date: | Jul 19, 1994 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 020222
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | COLESTID | colestipol hydrochloride | TABLET;ORAL | 020222-001 | Jul 19, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription